Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Richard Brown

Nuclear Medicine Ann Arbor, MI Medical Doctor

NPI 1265524292 CMS profile 940777

1500 E Medical Center Dr, Ann Arbor, MI 48109

Open in the dashboard

General payments

$318

15 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Richard Brown of Ann Arbor, MI is reported in the CMS Open Payments database as having received $318 across 15 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 58th percentile of Nuclear Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $88 4
2023 General $19 1
2021 General $18 1
2020 General $98 4
2019 General $97 5

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Richard Brown
  • Nuclear Medicine median
  • Middle half of Nuclear Medicine
  • National median

In program year 2025, general payments to Richard Brown were reported at $88. Among 197 Nuclear Medicine profiles paid that year, the median was $146 and the middle half received between $40 and $372.

Show as a table
Year Richard Brown Nuclear Medicine median Middle half National median
2019 $97 $125 $54–$531 $163
2020 $98 $99 $34–$2,125 $114
2021 $18 $96 $22–$874 $132
2022 $0 $102 $38–$240 $149
2023 $19 $123 $51–$257 $160
2024 $0 $121 $51–$390 $164
2025 $88 $146 $40–$372 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Supernus Pharmaceuticals, Inc. $194 9 payments
  2. Dexcom, Inc. $46 2 payments
  3. Scpharmaceuticals Inc. $42 2 payments
  4. Pfizer Inc. $19 1 payment
  5. Evoke Pharma, Inc. $18 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $318 15 payments
Products named General payments · program years 2019–2025
  1. TROKENDI XR $162 8 payments
  2. Dexcom G6 Transmitter $46 2 payments
  3. FUROSCIX $42 2 payments
  4. OXTELLAR XR $33 1 payment
  5. OXBRYTA $19 1 payment
  6. GIMOTI $18 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 16 billing codes

Paid by Medicare

$4,887

Medicare's payments for the services billed

Medicare patients

111

Average age 69

Services billed

125

55 women, 56 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 69%
Cancer 57%
Arthritis 43%
Diabetes 35%
Chronic kidney disease 30%
Ischemic heart disease 28%
Depression 27%
Heart failure 21%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

15 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nuclear Medicine in Michigan

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record